Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
Portfolio Pulse from Benzinga Newsdesk
Jacobs Solutions has been selected by Fujifilm Diosynth Biotechnologies to support the delivery of a $1.2 billion expansion of a large-scale cell culture contract manufacturing site in Holly Springs, North Carolina.
June 27, 2024 | 11:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jacobs Solutions has been chosen by Fujifilm Diosynth Biotechnologies to assist in a $1.2 billion expansion project for a cell culture manufacturing site in North Carolina. This partnership could lead to increased revenue and enhanced market position for Jacobs Solutions.
The selection of Jacobs Solutions for a significant $1.2 billion project indicates a strong partnership and potential for increased revenue. This project enhances Jacobs' market position in the biotech sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100